Invention Grant
- Patent Title: Substituted 2,4-diaminopyrimidines as kinase inhibitors
-
Application No.: US15080351Application Date: 2016-03-24
-
Publication No.: US09987276B2Publication Date: 2018-06-05
- Inventor: Juswinder Singh , Russell C. Petter , Richland Wayne Tester , Arthur F. Kluge , Hormoz Mazdiyasni , William Frederick Westlin, III , Deqiang Niu , Lixin Qiao
- Applicant: Celgene CAR LLC
- Applicant Address: BM Pembroke
- Assignee: Celgene CAR LLC
- Current Assignee: Celgene CAR LLC
- Current Assignee Address: BM Pembroke
- Agency: Choate, Hall & Stewart LLP
- Agent Kristen C. Buteau
- Main IPC: C07D239/48
- IPC: C07D239/48 ; A61K31/505 ; C07D239/47 ; C07D401/14 ; C07D403/12 ; C07D407/12 ; C07D413/12 ; C07D413/14 ; C07D471/04 ; C07D487/04 ; C07D487/18 ; C07D401/12 ; C07D417/14 ; A61K31/506 ; A61K31/5377
Abstract:
The present invention provides 2,4-diaminopyrimidines, and/or pharmaceutically acceptable compositions thereof, as kinase inhibitors.
Public/Granted literature
- US20160303121A1 HETEROARYL COMPOUNDS AND USES THEREOF Public/Granted day:2016-10-20
Information query
